1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "郭佳南" 6 results
        • 抗癲癇藥物與自殺的關系——國際抗癲癇聯盟治療方法委員會手術治療協作組報告

          在2008年, 美國食品及藥品管理局(Food and drug administration, FDA)警告醫務工作者關于接受抗癲癇藥物(AEDs)治療的患者自殺觀念及自殺行為的風險均有增高。自此以后, 一系列回顧性隊列研究及病例對照研究均致力闡明這一議題, 但不同研究的結果卻相互矛盾。這是一份來自國際抗癲癇聯盟(ILAE)神經心理生物學工作組的專家共識。盡管部分(并非全部)AEDs與治療中出現的自殺觀念與自殺行為相關(目前預計風險很低), 但仍需要進一步評估。此外, 停止AEDs治療或拒絕開始AEDs治療會明顯加重病情, 帶來嚴重后果甚至引起患者死亡。癲癇患者的自殺問題是多因素的, 不同的變量在其中發揮作用。臨床醫生應當注意觀察并選用合適的篩查工具評估患者是否存在自殺的風險。必要時應當推薦患者去看精神科醫師, 即使患者出現自殺傾向也不應當停用AEDs。當啟用一種新的AED治療或替換AED時, 應注意詢問患者近期是否有情緒的改變或出現自殺觀念。關于治療時出現的精神異常事件等資料應被記錄, 不僅僅記錄治療相關的安全信息, 還應記錄對照研究的信息, 在患者開始新的AED治療時告知患者及家屬新藥上市的時間

          Release date: Export PDF Favorites Scan
        • 新型抗癲癇藥物在控制孕期癇性發作的效能

          評估新型抗癲癇藥物(AEDs)——拉莫三嗪、托吡酯與左乙拉西坦在患者妊娠期中控制癇性發作的效能。分析在澳大利亞登記數據庫中應用AEDs控制癇性發作的癲癇患者中1 534例次患者妊娠的數據。在澳大利亞癲癇登記的數據中,接受單種AED治療的1 111例次妊娠的患者中,妊娠期使用左乙拉西坦控制發作的患者的癇性發作控制率與服用傳統AEDs如卡馬西平、丙戊酸的發作控制率相近;優于拉莫三嗪、托吡酯在孕期的發作控制率。左乙拉西坦作為控制癲癇患者的妊娠期發作的藥物有應用前景。

          Release date: Export PDF Favorites Scan
        • 國際抗癲癇聯盟治療方法委員會手術治療協作組報告——海綿狀血管瘤所致癲癇治療的回顧及推薦

          顱內海綿狀血管瘤(Cerebral cavernous malformations, CCMs)是一種已被明確的, 最常見的單發病變, 約占人群的0.4%~0.9%。癲癇發作是CCMs患者最常見的癥狀, 并嚴重影響患者的社會功能和生活質量。然而在接受手術切除治療的CCMs所致癲癇(CCMs related epilepsy, CRE)患者中僅有75%達到無癲癇發作。這是由于對致癇灶區域評估的不充分所致。國際抗癲癇聯盟(ILAE)治療方法委員會手術治療協作組及受邀專家回顧了與CRE相關的文獻資料, 提出以下觀點:根據診斷評估及針對病因的特殊處理不同, 推薦使用"確定的CRE"與"可能的CRE"來描述診斷。未來需要前瞻性的臨床研究來明確CRE的最佳手術時機及手術方案, 以及含鐵血黃素沉積邊緣與致癇灶之間的關系。

          Release date: Export PDF Favorites Scan
        • 國際抗癲癇聯盟診斷方法委員會兒科手術治療協作組報告——診斷性檢查在可外科治療的兒童癲癇中的應用

          對于經過嚴格篩選的兒童耐藥性局灶性癲癇病例, 外科手術是取得無癇性發作的成功手段。醫學技術的發展使癲癇患者可以獲得更精準的術前評估, 同時患者獲得癲癇外科手術治療的機會也有所增加。如今已在臨床應用的癲癇灶評估方法不僅耗費資源而且在特定病例中不起作用, 抑或是副作用大。因此有必要及時制定標準化的術前評估流程。各項檢查在特定臨床病理類型的病例中的作用尚缺乏1級或2級證據支持。基于這一現狀, 國際抗癲癇聯盟(ILAE)的診斷與兒科學組的兒童癲癇外科協作組將各成員間的共識總結為專家建議發表。旨在減少將各項檢查的利用不足, 同時促進臨床更靈活地運用各項檢查, 使現有的兒童癲癇中心盡可能標準化地進行癲癇的術前評估。

          Release date: Export PDF Favorites Scan
        • Efficacy of low to moderate doses of levetiracetam as initial monotherapy in adult patients with partial epilepsy

          Objective To explore the efficacy of low to moderate doses of levetiracetam in adult patients with newly diagnosed partial epilepsy and possible predictors for poor treatment response. Methods We retrospectively analyzed the clinical data of patients treated in West China Hospital from March 2011 to December 2015 whose clinical data were input into the Epilepsy database. Patients with newly diagnosed partial epilepsy and whose initial anti-epileptic drug was levetiracetam were screened out for this study. Their clinical data, especially responses to the treatment of levetiracetam were reviewed. Results Ninety-six patients were included in this study. Seventy-one of them achieved seizure-free for a complete year after initial treatment of levetiracetam. Forty-eight patients (50.0%) achieved seizure-free with levetiracetam monotherapy; 23 patients (24.0%) achieved seizure-free for one year with levetiracetam combination therapy. Sixty-nine (97.2%) of the 71 patients achieved seizure-free with low to moderate doses of levetiracetam (500 to 1 500 mg/day), with or without combination of other antiepileptic drugs. High baseline seizure frequency before initial therapy was an independent predictor of poor levetiracetam response in this multivariate logistic regression mode (P=0.019). Conclusions Low to moderate levetiracetam is both effective and well tolerated in newly diagnosed partial epilepsy patients. High baseline seizure frequency before initial therapy is an independent predictor of poor levetiracetam response.

          Release date:2017-05-18 01:09 Export PDF Favorites Scan
        • The investigation of diagnosis and treatment for status epilepticus in some hospitals of China

          Objective To investigate the diagnosis and treatment of status epilepticus in hospitals of different levels and the knowledge of status epilepticus in clinical physicians, in order to better guide clinical education in the future. Methods From August 2014 to August 2015, a questionnaire was designed and used to investigate the general situation of the hospital, the diagnosis of status epilepticus and the clinical practice among trainee doctors and students in the epilepsy training class in the Neurological Intensive Care Unit and the Department of Neurology of West China Hospital, Sichuan University. The results of the investigation were statistically analyzed. Results Ninety questionnaires were distributed, and all the questionnaires were retrieved with validity. The number of investigated physicians was 42 (46.7%) from the Department of Neurology, 6 (6.7%) from the Department of Neurosurgery, 30 (33.3%) from the Intensive Care Unit and 12 (13.3%) from other departments. Twenty-seven (30.0%) physicians were from class Ⅲ grade A hospitals, 31 (34.4%) from class Ⅲ grade B hospitals, and 32 (35.6%) from class Ⅱ grade A hospitals. All the class Ⅲ hospitals and 53.1% of class Ⅱ hospitals had electroencephalograph monitoring facilities. The proportion of status epilepticus patients ranged from 0.5% to 10.0% in different hospitals. There were great differences in the identification and treatment of convulsive status epilepticus among different hospitals. Conclusions Status epilepticus is a common emergency. Questionnaire survey is an effective means to reflect the difference in identifying and treating the emergency among different departments and hospitals. It can guide clinical education and promote the identification and treatment of the emergency more accurately in doctors of all levels.

          Release date:2017-05-18 01:09 Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品